Related Experiment Videos
Long-term results with the White glaucoma pump-shunt
F Davidovski1, R H Stewart, R L Kimbrough
1Conner Glaucoma Center, University of Texas Health Science Center, Department of Ophthalmology, Houston 77025.
Summary
This study evaluated the White glaucoma pump-shunt in 16 eyes, finding no complete successes. The qualified success rate of 31.3% for glaucoma treatment was significantly lower than other seton devices.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Medical Devices
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Glaucoma drainage devices (setons) are used to manage intraocular pressure (IOP) in refractory glaucoma.
- The White glaucoma pump-shunt is a specific type of seton device.
Purpose of the Study:
- To evaluate the efficacy and safety of the White glaucoma pump-shunt in a diverse patient population.
- To determine the success rate of the White glaucoma pump-shunt in lowering intraocular pressure.
- To compare the outcomes of the White glaucoma pump-shunt to other glaucoma drainage devices.
Main Methods:
- A retrospective case series of 16 eyes in 15 patients undergoing White glaucoma pump-shunt implantation.
- Patients aged 2 to 76 years with various types of glaucoma were included.
- Outcomes measured included intraocular pressure, visual acuity, pain, and need for medical treatment.
Main Results:
- No complete successes were achieved in the study cohort.
- Five eyes (31.3%) achieved "qualified success" (IOP ≤ 21 mm Hg with medical treatment, no pain, no significant visual acuity loss).
- This qualified success rate is notably lower than reported rates for alternative glaucoma setons.
Conclusions:
- The White glaucoma pump-shunt demonstrated a low qualified success rate in this series.
- Further research is needed to understand the limitations of this device compared to other setons.
- The findings suggest caution in the use of the White glaucoma pump-shunt for glaucoma management.